glp-1 obesity drugs news today 2025 As continue to gain popularity for weight loss, a lesser-known side effect is drawing attention from podiatrists: โOzempic feet.โ Story๐below 9 Obesity Drugs to be
Description
Semaglutide for managing overweight and obesity recommendations (TA875)

Strong demand for metabolic disorder therapies is expected to continue driving market progression over the forecast period

The concentration printed on your vial label is the only variable you need

Her lab has shown that GLP-1 signaling through serotonin neurons contributes to reduced food intake, and animal studies suggest broader effects on mood and emotionality

The trial showed a reduced risk of severe hypoglycemia, bone and joint injuries, and acute kidney injury compared to placebo, further confirming the safety and efficacy of Liraglutide in this patient population [91]

Theyre mostly gastrointestinal, Shah explains
